CDC42 and cancer: Analyzing the VEGF-CDC42-p38 MAPK signaling pathway enhances our understanding of how PGCCs and their offspring invade and spread, identifies potential targets to halt cancer metastasis and relapse, and potentially extends patient lifespan.